Claire L Mackintosh
Overview
Explore the profile of Claire L Mackintosh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
391
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brito-Mutunayagam S, Marr E, Hamilton K, Kenyon R, Reilly J, Rae H, et al.
Future Healthc J
. 2024 May;
11(2):100134.
PMID: 38751490
No abstract available.
2.
Scopazzini M, Cave R, Mutch C, Ross D, Bularga A, Chase-Topping M, et al.
Int J Equity Health
. 2023 Oct;
22(1):205.
PMID: 37794428
Background: Sars-CoV-2, the causative agent of COVID-19, has led to more than 226,000 deaths in the UK and multiple risk factors for mortality including age, sex and deprivation have been...
3.
Mutch C, Ross D, Bularga A, Cave R, Chase-Topping M, Anand A, et al.
J R Coll Physicians Edinb
. 2022 Nov;
52(3):204-212.
PMID: 36369813
Background: COVID-19 mortality risk factors have been established in large cohort studies; long-term mortality outcomes are less documented. Methods: We performed multivariable logistic regression to identify factors associated with in-patient...
4.
Wedekind L, Noe A, Mokaya J, Tamandjou C, Kapulu M, Ruecker A, et al.
Wellcome Open Res
. 2021 Aug;
6:142.
PMID: 34381874
Higher academic institutions in the UK need to drive improvements in equity, diversity, and inclusion (EDI) through sustainable practical interventions. A broad view of inclusivity is based on an intersectional...
5.
Russell C, Laurenson I, Evans M, Mackintosh C
JAC Antimicrob Resist
. 2021 Jul;
1(2):dlz042.
PMID: 34222916
Background: As meropenem is a restricted antimicrobial, lessons learned from its real-life usage will be applicable to antimicrobial stewardship (AMS) more generally. Objectives: To retrospectively evaluate meropenem usage at our...
6.
Lee K, Doudesis D, Ross D, Bularga A, Mackintosh C, Koch O, et al.
BMC Infect Dis
. 2021 Apr;
21(1):318.
PMID: 33823800
Background: Accurate diagnosis in patients with suspected coronavirus disease 2019 (COVID-19) is essential to guide treatment and limit spread of the virus. The combined nasal and throat swab is used...
7.
Russell C, Whittaker E, Dee D, Farquhar E, Saenz de Villaverde A, Evans M, et al.
Clin Infect Dis
. 2020 Apr;
71(10):e710-e713.
PMID: 32266388
Among 200 patients developing hospital-acquired pneumonia (HAP) outside the intensive care unit, 61% were treated empirically without broad-spectrum Gram-negative coverage, with clinical cure in 69.7%. Lower disease severity markers (systemic...
8.
Hill K, Russell C, Clifford S, Templeton K, Mackintosh C, Koch O, et al.
J Infect
. 2020 Mar;
81(1):147-178.
PMID: 32205138
Since its identification in December 2019, SARS-CoV-2 has infected 125,048 persons globally with cases identified in 118 countries across all continents. We report on the Scottish index case of SARS-CoV-2...
9.
Charlier C, Johannessen I, Mackintosh C, Wilks D, Cauda R, Wolf F, et al.
Med Teach
. 2017 May;
39(9):981-986.
PMID: 28552022
Context: The emerging global-health paradigm requires medical teaching to be continuously redefined and updated; to this end, transnational approaches should be encouraged and medical training harmonized. Infectious diseases (ID) teaching...
10.
Stockdale A, Mackintosh C, Roberston K, Helgason K
Am J Med
. 2014 Mar;
127(5):e5-6.
PMID: 24581952
No abstract available.